RESTRICTED STOCK (Details Narrative 1) (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Stock Options And Restricted Stock
Aggregate restricted shares of Common Stock pursuant to 2008 plan	118,375
Fair Value of restricted stock	$ 97,324
Share-based compensation expense	161,000	29,000
Restricted stock to vest upon FDA approval	3,178,688
Total unrecognized compensation expense	$ 1,713,000
FDA Approval [Member]
Stock Options And Restricted Stock
Restricted stock to vest upon FDA approval	1,679,594
Sale of Company [Member]
Stock Options And Restricted Stock
Restricted stock to vest upon FDA approval	220,000
Yearly [Member]
Stock Options And Restricted Stock
Restricted stock to vest upon FDA approval	920,364